DORIS ORTIZ: Open Payments
NPI 1366966863 · JUPITER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 16 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $584 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
| Alkermes, Inc. | 2 | $46 |
| Indivior Inc. | 1 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $34 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| Braeburn Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: ABILIFY MAINTENA, SUBLOCADE, AUSTEDO XR, INGREZZA, SPRAVATO, ABILIFY ASIMTUFII, ARISTADA, BRIXADI.
Industry payments across FL — which companies pay providers there.
